TIAP

Toronto, Canada
Early-stage health science technologies are developed into business ventures by TIAP.

About TIAP

TIAP is a company based in Toronto (Canada). It operates as a HealthTech and Managed Services. TIAP offers products and services including Venture Building, Advisory Services, and Investment Support.

  • Headquarter Toronto, Canada
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website tiap.ca
  • Social LinkedIn X

Products & Services of TIAP

TIAP offers a comprehensive portfolio of products and services, including Venture Building, Advisory Services, and Investment Support.

Venture Building
Health Science Innovation

Early-stage health science technologies are transformed into ventures.

Advisory Services
Health Science Innovation

Ideas are de-risked through expert financial and scientific advice.

Investment Support
Health Science Innovation

Early-stage innovations are funded and connected to capital sources.

People of TIAP

5 people are tracked at TIAP (4 in leadership, 1 in team).

NameRoleGroup
Parimal Nathwani
President And CEOLeadership
Prakash Gowd
Vice PresidentLeadership
Philip Goldbach
Director, Technology & Venture DevelopmentLeadership
Ido Kaminsky
Director, Technology & Venture DevelopmentLeadership
Mobeen Lalani
Manager, Technology And Venture DevelopmentTeam
Premium access

Complete people profiles for TIAP

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Similar companies to TIAP

10 companies that operate in the same segment as TIAP (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Genetic services are provided by Colossal's laboratory operations.
2021Austin, Texas, United StatesUSD 617.6 M––
Research lab engaged in pharmacological measurements on therapeutic protein variants
2018United StatesUSD 78.19 M–22
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
2004Ahmedabad, Gujarat, India–USD 50.52 M902
Generic injectables for oncology and anesthesiology are manufactured.
1989Hyderabad, Telangana, India–USD 4.22 M228
Medical research labs are provided by GALY for scientific purposes.
2018Boston, Massachusetts, United StatesUSD 61.59 M–25
Laboratory focused on biotechnology & molecule research services
2018Cambridge, Massachusetts, United StatesUSD 32.68 M––
Laboratory delivers discovery & research in nuclear and particle physics
1947United States––2,436
Research and manufacturing of hemp products are conducted by BRC.
2017Monterey, California, United StatesUSD 25.26 M–16
Genome sequencing studies are conducted for medical research purposes.
2020Cambridge, Cambridgeshire, United KingdomUSD 11.26 M–12
Novel immunotherapy therapeutic targets are discovered through laboratory research.
2019Branford, Connecticut, United StatesUSD 92 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about TIAP

TIAP is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

TIAP is focused on transforming early-stage health science innovations into viable business ventures. Operations are centered in the health technology sector, bridging funding gaps for member institutions. Support is provided through venture building, expert advisory services, investment in innovations, and connections to industry and investors. Programs such as LAB150-NextGen, UTEST, Venture Builder, Critical Technologies, and Portfolio Management are offered to advance technologies to market-ready states. A global and local network is leveraged to facilitate collaboration and growth.

TIAP offers Venture Building, Advisory Services, and Investment Support.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available